Gilead Sciences said it will join with other drugmakers to manufacture and sell its Covid-19 treatment remdesivir outside of the U.S., farming out production of the medicine to ensure supply meets global demand.
Gilead Seeks Deals to Boost Supply of Covid-19 Drug
Comment
Show comments
Hide Comments
